※News:


  • 2016.04.20 Vigenent Inc., a Wholly Owned Subsidiary of Visgeneer Inc., Received European patent NO 2441433; Title: OLLEYA MARILIMOSA AND ITS USE IN A METHOD FOR THE PREPARATION OF A COMPOSITION COMPRISING ZEAXANTHIN.
  • 2015.04.01 Received R.O.C patent NO. M498314; Title: STRIP FOR TESTING PHYSICAL DATA
  • 2015.02.01 Received R.O.C patent NO. M494911; Title: CODELESS TEST STRIP
  • 2015.02.01 Received R.O.C patent NO. M494910; Title: STRIP FOR TESTING BLOOD GLUCOSE, URIC ACID AND CHOLESTEROL
  • .02.01 Received R.O.C patent NO. M494909; Title: STRIP FOR TESTING BLOOD GLUCOSE AND URIC ACID
  • 2014.09.21 Received R.O.C patent NO. M486398; Title: STRUCTURE OF BLOOD GLUCOSE TEST STRIP
  • 2013.5.27 Visgeneer Cosmetic factory has received ISO22716:2007 Cosmetics GMP Compliance certification from BUREAU VERITAS.
  • 2012.06.14 The annual growth rate of Visgeneer’s blood glucose meter and test strip is 50%.
  • 2012.02.07 Dr. Ken-Shwo Dai leads Visgeneer toward the broad road of the biotech industry.
  • 2012.02.08 Germany patent NO 60 2006 021 742.0 ; Title: Human Ron-Related Gene Variant Associated with Cancers.
  • 2012.01.10 European patent NO 1892291 ; Title: Human Ron-Related Gene Variant Associated with Cancers.
  • 2011.07.12 US patent NO 7,977,470; Title: Human Ron-Related Gene Variant Associated with Cancers.
  • 2011.03.08 US patent NO 7,902,347; Title: Human Ron-Related Gene Variant Associated with Cancers.
  • 2010.03.10 European patent NO 1903109; Title: HUMAN PROTEIN PHOSPHATASE WITH EF-HANDS-1(PPEF-1)-RELATED GENE VARIANT ASSOCIATED WITH T-CELL LYMPHOBLASTIC LYMPHOMA.
  • 2010.02.22 Vigenent Inc., a Wholly Owned Subsidiary of Visgeneer Inc., received an approval of “Emerging, Important, and Strategic Industries” from the Industrial Department Bureau, Ministry of Economic Affairs.(NO 0990143010)
  • 2010.02.22 Received an approval of “Emerging, Important, and Strategic Industries” from the Industrial Department Bureau, Ministry of Economic Affairs.(NO 09801039840)
  • 2010.02.21 Received R.O.C patent NO. D133384; Title: Biosensor with All-In-One feature.
  • 2010.02.09 The investment plan in Hsinchu Biomedical Science Park proposed by Vigenent Inc., a Wholly Owned Subsidiary of Visgeneer Inc., has been approved by the National Science Council (NSC) of the Executive Yuan.
  • 2010.02.01 An interview of Dr. Ken-Shwo Dai, president of Visgeneer Inc., was published in the 2010 February edition of Industrial Technology Research Institute entitled “Visgeneer Making Their Own Rules In Medical Device”
  • 2009.11.23 Dr. Ken-Shwo Dai, President of Visgeneer Inc., received an interview from the Economic Daily News. The interview was published under the title of 「Using advanced technology to open Biotech market」.
  • 2009.10.27 Visgeneer Inc. extraordinary shareholder’s meeting passed a resolution in setting up a wholly-owned subsidiary company.
  • 2009.10.27 Dr Ken-Shwo Dai, President of Visgeneer Inc., received an interview from the Economic Daily News. The interview was published under the title of 「Visgeneer has an advantage in the cost on mass production of macular pigment」.
  • 2009.09. 17 Visgeneer is granted with a ‘Small Business Innovation Research (SBIR) project entitled “The study of functional activity and optimum operating conditions for the macular pigment generated by a novel strain of Olleya marilimosa” by the Department of Industrial Technology, Ministry of Economic Affairs.
  • 2009.09.04 Visgeneer Medical equipment product (Glucose meter & test strips) acquired Tender from India government.
  • 2009.08.26 A collaborative research project entitled “Correlative analysis on the blood glucose and uric acid concentrations in diabetic patients” is established between Wei-Gong Memorial Hospital and Visgeneer Inc.
  • 2009.08.19 Visgeneer Inc. has received a certification of "Emerging, Important, and Strategic Industries" from the Industrial Department Bureau, Ministry of Economic Affairs.(NO 09805024190 ).
  • 2009.08.15 US patent NO 7,452,985; Title: Human Ron-Related Gene Variant Associated with Cancers.
  • 2009.03.01 Visgeneer acquired an approval from Chunghwa Post Co., Ltd. to sell Coresence skin care series at their distribution channels.
  • 2008.12.01 Received R.O.C patent NO. M346004; Title: A traveling biosensor with voice output and rechargeable function.
  • 2008.08.08 Visgeneer purchases a factory and office building in responding to the requirement of increasing production lines.
  • 2008.07.30 Visgeneer Inc. acquired an approval of adding new production items (CODE 09700612140) on the previous "Newly Emerging, Important, and Strategic Industries" (CODE 09600967610) certified by the Industrial Department Bureau, Ministry of Economic Affairs.
  • 2008.07.28 We attended AACC Exhibition in Washington D.C, USA (7.28~08.01) and demonstrated Blood Glucose Monitoring System and 3 in 1 Remote Health Monitoring System.
  • 2008.06.09 Taiwan Fertilizer, a listed company (1722), acquired a director and a supervisor of the board in the shareholder meeting of Visgeneer inc. in 2008.
  • 2008.06.06 Economic Daily News: Revenue has increased in 2008.
  • 2008.02.22 Visgeneer acquired blood glucose monitor approval from the State Food and Drug Administration of the PRC.
  • 2008.01.23 Received an approval of “Emerging, Important, and Strategic Industries” from the Industrial Department Bureau, Ministry of Economic Affairs.(NO 09600967610)
  • 2007.11.26 Meeting of stockholders elected Taiwan Fertilizer Co., Ltd. as a Member of Board,Visgeneer Inc.
  • 2007.11.14~17 Visgeneer Inc. participated in Dusseldorf, Germany's Medica 2007 Medical Devices Exhibition.
  • 2007.05.17 Visgeneer Inc. has received a certification of "Emerging, Important, and Strategic Industries" from the Industrial Department Bureau, Ministry of Economic Affairs(NO 09605022930).
  • 2007.03.02 Visgeneer eBsensor blood glucose factory is approved with Good Manufacturing Practice of Medical Device. (GMP Certification No. 0960302217)
  • 2007.02.27 Institutional Review Board of Hsin Chu General Hospital, Department of Health has passed a resolution on 8/Feb/07 and signed a research collaboration contract with Visgeneer Inc. on 27/Feb/2007.
  • 2007.01.15 Visgeneer has received CE Mark (CE0123) for the eBsensor Blood Glucose Monitoring System.
    certification from TUV PS.
  • 2007.01.15 Visgeneer medical device factory has received ISO13485 : 2003.
  • 2006.12.28 eBsensor Blood Glucose Monitoring System received US FDA 510K approval (No. K062555).
  • 2006.12.22 Received P.R.O.C patent NO 876373; Title: Structures of biosensor strips.
  • 2006.12.15 Visgeneer Cosmetic factory has received ISO9001:2000 certification from TUV PS.
  • 2006.12.11 Received ‘Small Business Innovation Research (SBIR) Subsidy Plan 2006’ entitled “A study of pathogenesis of T-cell lymphoblastic lymphoma” from the Industrial Department Bureau, Ministry of Economic Affairs.
  • 2006.11.27 eBsensor Blood Glucose is approved with EN61010-1(2001) Standard.
  • 2006.11.25 eBsensor Blood Glucose is approved with EN61326-1 Standard.
  • 2006.10.23 Received an approval of “Emerging, Important, and Strategic Industries” from the Industrial Department Bureau, Ministry of Economic Affairs. (NO 09500828690)
  • 2006.9.21 The clinical study of eBsensor entitled "Clinical evaluation of the eBsensor hand-held blood glucose monitoring system" was accepted for publication in Clin Chim Acta
  • 2006.9.11 Received R.O.C patent NO. M297470; Title: Structures of biosensor strips.
  • 2006.8.15 eBsensor Blood Glucose is approved with EN60601-1(1990) +A1(1993) +A2(1995) +A13(1996) Standard.
  • 2006.8.14 eBsensor Blood Glucose is approved with EN60601-1-2 : 2000 Standard.


 

 

 
    HOMEAbout UsOur ProductsNews RoomInformationContact Us Chinese  
 
©2007 Visgeneer Inc. All Rights Reserved.